What's New In Decentralized Clinical Trials

In a sponsored edition of the Big4Bio Podcast, Veristat experts, renowned for their proficiency in the field of clinical research, share the most recent and groundbreaking developments and trends that have emerged as the role of Decentralized Clinical Trials (DCTs) continues to evolve at a rapid pace.

Specifically, the speakers dive into the industry's resulting shift after COVID-19 disrupted traditional clinical trials and accelerated the adoption of DCTs. By embracing these new approaches, leaders within the space have reported improvements in the recruitment and retention of patients, relieving the travel burden for participants, and removing geographical barriers to eligibility.

Listen in as Shaheen Limbada, Executive Vice President of Innovation and Strategy at Veristat, talks about how the contract research organization Veristat is leveraging virtual trial tools and strategies to increase efficiencies and save sponsors time and costs.